Udemy - Coronavirus Story Perception By Using Maram Shtaya Approach

seeders: 4
leechers: 11
updated:

Download Fast Safe Anonymous
movies, software, shows...

Files

[ CourseWikia.com ] Udemy - Coronavirus Story Perception By Using Maram Shtaya Approach
  • Get Bonus Downloads Here.url (0.2 KB)
  • ~Get Your Files Here ! 1 - Background Literature Review Statement of the Problem & Rational of the Course
    • 1 - Background of the Course.mp4 (95.8 MB)
    • 1 - Multiple Choice.html (0.0 KB)
    • 2 - Background of the Course.html (6.2 KB)
    • 2 - Background-of-the-Course-Coronavirus-Story.pdf (142.5 KB)
    • 3 - Literature Review.mp4 (19.6 MB)
    • 4 - Literature Review.html (6.9 KB)
    • 4 - Literature-Review-Coronavirus-Story.pdf (152.5 KB)
    • 5 - Statement of the Problem and Rational of the Course.mp4 (20.3 MB)
    • 6 - Statement of the Problem and Rational of the Course.html (3.2 KB)
    • 6 - Statement-of-the-Problem-and-Rational-of-the-Course-Coronavirus-Story.pdf (85.4 KB)
    10 - Acute Respiratory Tract Contagions Pneumonia Hypoxaemia and ARDS
    • 10 - Multiple Choice.html (0.0 KB)
    • 61 - Acute Respiratory Tract Contagions.mp4 (63.8 MB)
    • 62 - Acute Respiratory Tract Contagions.html (4.2 KB)
    • 62 - Acute-Respiratory-Tract-Contagions-Coronavirus-Story.pdf (246.2 KB)
    • 63 - An Essential Reason of Pneumonia.mp4 (10.5 MB)
    • 64 - An Essential Reason of Pneumonia.html (2.7 KB)
    • 64 - An-Essential-Reason-of-Pneumonia-Coronavirus-Story.pdf (137.6 KB)
    • 65 - Hypoxaemia and Acute Respiratory Distress Syndrome ARDS.mp4 (6.4 MB)
    • 66 - Hypoxaemia and Acute Respiratory Distress Syndrome ARDS.html (2.3 KB)
    • 66 - Hypoxaemia-and-Acute-Respiratory-Distress-Syndrome-Coronavirus-Story.pdf (127.5 KB)
    11 - Coronaviruses CoVs Effects on Humans and Animals and Urbanization Consequences
    • 11 - Multiple Choice.html (0.0 KB)
    • 67 - Coronaviruses CoVs Effects on Humans and Animals.mp4 (65.9 MB)
    • 68 - Coronaviruses CoVs Effects on Humans and Animals.html (4.2 KB)
    • 68 - Coronaviruses-Effects-on-Humans-and-Animals-Coronavirus-Story.pdf (131.1 KB)
    • 69 - Urbanization Consequences.mp4 (12.5 MB)
    • 70 - Urbanization Consequences.html (3.8 KB)
    • 70 - Urbanization-Consequences-Coronavirus-Story.pdf (137.8 KB)
    12 - Coronavirus Control Procedures and Exposure to Somebody Who has COVID19
    • 71 - Coronavirus Control Procedures.mp4 (45.4 MB)
    • 72 - Coronavirus Control Procedures.html (2.7 KB)
    • 72 - Coronavirus-Control-Procedures-Coronavirus-Story.pdf (136.0 KB)
    • 73 - After Exposure to Somebody Who has COVID19.mp4 (13.7 MB)
    • 74 - After Exposure to Somebody Who has COVID19.html (3.2 KB)
    • 74 - After-Exposure-to-Somebody-Who-has-COVID-19-Coronavirus-Story.pdf (142.5 KB)
    13 - COVID19 Disease and Symptoms
    • 12 - Multiple Choice.html (0.0 KB)
    • 75 - SARS‑CoV‑2 Virus and COVID19 Disease.mp4 (39.8 MB)
    • 76 - SARS-CoV-2-Virus-and-COVID-19-Disease-Coronavirus-Story.pdf (152.0 KB)
    • 76 - SARS‑CoV‑2 Virus and COVID19 Disease.html (3.0 KB)
    • 77 - COVID19 Symptoms.mp4 (15.1 MB)
    • 78 - COVID-19-Symptoms-Coronavirus-Story.pdf (244.8 KB)
    • 78 - COVID19 Symptoms.html (3.6 KB)
    14 - Procalcitonin and Antibody Responses to SARSCoV2
    • 13 - Multiple Choice.html (0.0 KB)
    • 79 - Procalcitonin A BacteriaParticular Biomarker.mp4 (23.8 MB)
    • 80 - Procalcitonin A BacteriaParticular Biomarker.html (1.7 KB)
    • 80 - Procalcitonin-Coronavirus-Story.pdf (125.2 KB)
    • 81 - Antibody Responses to SARSCoV2 A Pivotal Concern.mp4 (12.1 MB)
    • 82 - Antibody Responses to SARSCoV2 A Pivotal Concern.html (3.7 KB)
    • 82 - Antibody-Responses-to-SARS-CoV-2-Coronavirus-Story.pdf (129.5 KB)
    15 - Suggestions Concerning Health Communication
    • 83 - Suggestions Concerning Health Communication.mp4 (12.3 MB)
    • 84 - Suggestions Concerning Health Communication.html (2.6 KB)
    • 84 - Suggestions-Concerning-Health-Communication-Coronavirus-story.pdf (143.4 KB)
    16 - Treatment of Patients with Coronavirus
    • 100 - 5 Anticoagulants and COVID19 Biomarkers – Part Two.html (3.2 KB)
    • 100 - Anticoagulants-and-COVID-19-Biomarkers-2.pdf (138.9 KB)
    • 101 - 6 NSAIDs Usage in Covid19 Patients.mp4 (22.4 MB)
    • 102 - 6 NSAIDs Usage in Covid19 Patients.html (1.6 KB)
    • 102 - NSAIDs-Usage-in-Covid-19-Patients-Coronavirus-story.pdf (125.3 KB)
    • 103 - 7 Bronchodilators Usage in Covid19 Patients.mp4 (4.0 MB)
    • 104 - 7 Bronchodilators Usage in Covid19 Patients.html (1.1 KB)
    • 104 - Bronchodilators-Usage-in-Covid-19-Patients-Coronavirus-story.pdf (82.9 KB)
    • 105 - 8 Gastrointestinal Agents Usage in COVID19 Patients.mp4 (6.4 MB)
    • 106 - 8 Gastrointestinal Agents Usage in COVID19 Patients.html (1.6 KB)
    • 106 - Gastrointestinal-Agents-Usage-in-COVID-19-Patients-Coronavirus-Story.pdf (125.3 KB)
    • 107 - 9 Antihypertensive Drugs Usage in COVID19 Patients.mp4 (5.3 MB)
    • 108 - 9 Antihypertensive Drugs Usage in COVID19 Patients.html (2.2 KB)
    • 108 - Antihypertensive-Drugs-Usage-in-COVID-19-Patients-Coronavirus-Story.pdf (127.4 KB)
    • 14 - Multiple Choice.html (0.0 KB)
    • 15 - Multiple Choice.html (0.0 KB)
    • 16 - Multiple Choice.html (0.0 KB)
    • 85 - Nutrition A Determinant Agent for Homeostasis.mp4 (65.1 MB)
    • 86 - Nutrition A Determinant Agent for Homeostasis.html (3.8 KB)
    • 86 - Nutrition-Coronavirus-Stroy.pdf (136.4 KB)
    • 87 - Some of Probable Therapeutics for Patients with Coronavirus.mp4 (10.3 MB)
    • 88 - Some of Probable Therapeutics for Patients with Coronavirus.html (3.9 KB)
    • 88 - Some-of-Probable-Therapeutics-for-Patients-with-Coronavirus-Coronavirus-Story.pdf (139.3 KB)
    • 89 - Pharmacological Treatment 1 Antimicrobials Usage in Covid19 Patients.mp4 (13.4 MB)
    • 90 - Antimicrobials-Usage-in-Covid-19-Coronavirus-Story.pdf (140.4 KB)
    • 90 - Pharmacological Treatment 1 Antimicrobials Usage in Covid19 Patients.html (4.5 KB)
    • 91 - 2 Corticosteroid Usage in Patients with Coronavirus.mp4 (15.8 MB)
    • 92 - 2 Corticosteroid Usage in Patients with Coronavirus.html (4.8 KB)
    • 92 - Corticosteroid-Usage-in-Patients-with-Coronavirus-Coronavirus-Story.pdf (140.8 KB)
    • 93 - 3 Antimalarial and Antiviral Agents Use in Covid19 Patients.mp4 (9.2 MB)
    • 94 - 3 Antimalarial and Antiviral Agents Use in Covid19 Patients.html (2.5 KB)
    • 94 - Antimalarial-and-Antiviral-Agents-Use-in-Covid-19-Coronavirus-Story.pdf (127.8 KB)
    • 95 - 4 Nacetylcysteine Usage in Covid19 Patients.mp4 (37.0 MB)
    • 96 - 4 Nacetylcystein

Description

Coronavirus Story Perception By Using Maram Shtaya Approach

https://CourseWikia.com

Last updated 4/2024
MP4 | Video: h264, 1280x720 | Audio: AAC, 44.1 KHz
Language: English (US) | Size: 1.88 GB | Duration: 5h 21m

Maram Shtaya Approach, Coronavirus Genome, Structure, Pathogenesis, and Treatment, COVID-19 Disease and Symptoms

What you'll learn
Maram Shtaya Approach
Significance of Maram Shtaya Approach
Transtheoretical Model (TTM)
The Four Structures of the TTM
Protection Motivation Theory (PMT)
The Structure of Protection Motivation Theory (PMT)
KAP Survey Model
Communication Theory
Normalisation Process Theory (NPT)
The Normalisation Process Theory (NPT) Prime Elements
Holism Theory
Complexity Theory
Coronavirus Expression
The Four Coronavirus Genera
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
The Coronavirus Genome and Structure
The Epidemiologic Coronavirus Realization
Coronavirus Expansion: A Central Worry
Coronavirus Phylogenetics and Taxonomy
Coronavirus Pathogenesis
Coronavirus Proteins, Receptor Interaction, Incorporation, and Entrance
Acute Respiratory Tract Contagions
An Essential Reason of Pneumonia
Hypoxaemia and Acute Respiratory Distress Syndrome (ARDS)
Coronaviruses (CoVs) Effects on Humans and Animals
Urbanization Consequences
Coronavirus Control Procedures
After Exposure to Somebody Who has COVID-19
SARS‑CoV‑2 Virus and COVID-19 Disease
COVID-19 Symptoms
Procalcitonin: A Bacteria-Particular Biomarker
Antibody Responses to SARS-CoV-2: A Pivotal Concern
Suggestions Concerning Health Communication
Nutrition: A Determinant Agent for Homeostasis
Some of Probable Therapeutics for Patients with Coronavirus
Antimicrobials Usage in Covid-19 Patients
Corticosteroid Usage in Patients with Coronavirus
Antimalarial and Antiviral Agents Use in Covid-19 Patients
N-acetylcysteine Usage in Covid-19 Patients
Anticoagulants and COVID-19 Biomarkers
NSAIDs Usage in Covid-19 Patients
Bronchodilators Usage in Covid-19 Patients
Gastrointestinal Agents Usage in COVID-19 Patients
Antihypertensive Drugs Usage in COVID-19 Patients
ECMO Machine, High-Flow Oxygen, Fluid management, and Spirometer Use
Drug Repurposing: A Prosperous Tactic
The COVID-19 Vaccine Scheme
The Improvement of SARS-CoV-2 Vaccines
Vaccine Platforms

Requirements
There are no prerequisites for this course; but a passion to read, understand and/or realize Coronavirus Story.



Download torrent
1.9 GB
seeders:4
leechers:11
Udemy - Coronavirus Story Perception By Using Maram Shtaya Approach


Trackers

tracker name
udp://tracker.torrent.eu.org:451/announce
udp://tracker.tiny-vps.com:6969/announce
http://tracker.foreverpirates.co:80/announce
udp://tracker.cyberia.is:6969/announce
udp://exodus.desync.com:6969/announce
udp://explodie.org:6969/announce
udp://tracker.opentrackr.org:1337/announce
udp://9.rarbg.to:2780/announce
udp://tracker.internetwarriors.net:1337/announce
udp://ipv4.tracker.harry.lu:80/announce
udp://open.stealth.si:80/announce
udp://9.rarbg.to:2900/announce
udp://9.rarbg.me:2720/announce
udp://opentor.org:2710/announce
µTorrent compatible trackers list

Download torrent
1.9 GB
seeders:4
leechers:11
Udemy - Coronavirus Story Perception By Using Maram Shtaya Approach


Torrent hash: 057DD2225DF9AC36F0888BF6C2D21519A6E47025